# Evaluation of the Efficacy and Safety of Insulin Detemir Compared With That of NPH Insulin in Subjects With Type 1 Diabetes.

> **NCT03220425** · PHASE3 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 752 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** Insulin detemir
- **DRUG:** NPH insulin

## Key facts

- **NCT ID:** NCT03220425
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-02-01
- **Primary completion:** 2001-11-12
- **Final completion:** 2001-11-12
- **Target enrollment:** 752 (ACTUAL)
- **Last updated:** 2017-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03220425

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03220425, "Evaluation of the Efficacy and Safety of Insulin Detemir Compared With That of NPH Insulin in Subjects With Type 1 Diabetes.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03220425. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*